Autotransfusion after coronary artery bypass surgery: is there any benefit?

N Bouboulis1, M Kardara, P J Kesteven

  • 1Cardiothoracic Department, Freeman Hospital, Newcastle upon Tyne, United Kingdom.

Insights

Postoperative autotransfusion of shed mediastinal blood did not reduce homologous blood needs in coronary artery bypass grafting patients. This technique did not prove beneficial in reducing blood transfusion requirements.

Area of Science:

  • Cardiovascular Surgery
  • Transfusion Medicine
  • Critical Care Medicine

Background:

  • Postoperative salvage autotransfusion of shed mediastinal blood is a cost-effective technique.
  • Its efficacy and safety require evaluation in patients undergoing coronary artery bypass grafting (CABG).

Purpose of the Study:

  • To evaluate the efficacy and safety of postoperative salvage autotransfusion of shed mediastinal blood.
  • To determine if this technique reduces the need for homologous blood transfusions in CABG patients.

Main Methods:

  • Randomized controlled trial with 75 consecutive patients undergoing CABG.
  • Autotransfusion group (n=42) received autotransfusion; control group (n=33) received standard drainage.
  • Both groups received homologous blood transfusion if hematocrit fell below 30%.

Main Results:

  • No significant difference in packed red cell requirements between groups (84.8% control vs. 80.9% autotransfusion).
  • Autotransfusion group showed higher prothrombin time (p=0.03) and elevated fibrin degradation products (p<0.002).
  • Autotransfusion group lost more red cells in mediastinal drains, despite receiving more red cells.

Conclusions:

  • Postoperative autotransfusion of shed mediastinal blood did not demonstrate benefit in reducing homologous blood requirements for CABG patients.
  • The technique did not prove advantageous in minimizing postoperative transfusion needs.
  • Further research may be needed to clarify the role of autotransfusion in specific patient populations.